Bayview Pharmacy's Itraconazole 0.2%/Mupirocin 0.2%/Triamcinolone 0.03% Nasal Spray is a specially formulated liquid medication. Delivered as a spray, it is designed for direct administration into the nasal cavity. This targeted approach is used to effectively treat conditions such as rhinitis, sinusitis, nasal polyps, allergic rhinitis, and chronic rhinosinusitis.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specialized compounded nasal spray formulation of Itraconazole 0.2%/Mupirocin 0.2%/Triamcinolone 0.03%. This unique formulation is specifically designed to address a range of conditions such as sinusitis, rhinitis, and nasal polyps.
The Itraconazole component is an antifungal agent that works to reduce inflammation and prevent fungal infections. Mupirocin, an antibiotic, aids in reducing bacterial infections. Triamcinolone, a corticosteroid, contributes to the reduction of inflammation and swelling. Together, these ingredients create a potent formulation that targets and treats the root causes of these conditions.
This nasal spray formulation is a liquid delivered in a spray form, specifically designed for administration into the nasal cavity. It provides targeted local or systemic effects through the nostrils. It works to reduce inflammation and swelling, as well as prevent and treat fungal and bacterial infections.
Its ease of use and direct administration into the nasal cavity make it a convenient option for treatment.
Its ease of use and direct administration into the nasal cavity make it a practical choice for patient care.
If you have any questions about this formulation or its usage, please do not hesitate to contact us at Bayview Pharmacy. We are committed to providing the best possible treatment options for your patients and are here to assist with any inquiries you may have.
Itraconazole 0.2%/Mupirocin 0.2%/Triamcinolone 0.03% Nasal Spray is a compounded formulation designed for targeted delivery into the nasal cavity. This unique combination of medications is indicated for the treatment of rhinitis, sinusitis, and otitis media caused by organisms susceptible to the active ingredients.
Itraconazole, an antifungal agent, works by inhibiting the growth of fungi. Mupirocin, an antibiotic, functions by inhibiting the growth of bacteria. Triamcinolone, a corticosteroid, reduces inflammation. Together, these medications effectively alleviate symptoms associated with rhinitis, sinusitis, and otitis media, such as nasal congestion, sneezing, and itching.
It is crucial to note that this formulation should not be used by patients with a known hypersensitivity to any of the components. It is also contraindicated in patients with a history of tuberculosis, fungal infections, or viral infections. Patients should be monitored for signs of systemic absorption of the corticosteroid, which may include weight gain, increased blood pressure, and changes in mood or behavior.
Patients are advised to use this formulation as directed and to avoid contact with the eyes. If any irritation or other adverse reactions occur, patients should discontinue use and contact their healthcare provider immediately.
If you have any questions about the use of Itraconazole 0.2%/Mupirocin 0.2%/Triamcinolone 0.03% Nasal Spray, please do not hesitate to reach out for further information.
Itraconazole 0.2%/Mupirocin 0.2%/Triamcinolone 0.03% Nasal Spray is a compounded formulation designed to treat a variety of nasal conditions. This unique combination of medications works synergistically to provide relief from symptoms associated with conditions such as sinusitis, allergic rhinitis, and nasal polyps.
Itraconazole, an antifungal medication, works by inhibiting the growth of fungi. This is particularly useful in treating conditions where fungal infections are a contributing factor. Mupirocin, an antibiotic, aids in the treatment by eliminating bacteria. This is crucial in preventing and treating bacterial infections that can exacerbate nasal conditions. Triamcinolone, a corticosteroid, reduces inflammation, providing relief from swelling and discomfort.
This nasal spray is designed for administration into the nasal cavity. The liquid formulation is delivered in a spray form, providing targeted local or systemic effects through the nostrils. This ensures that the medication is delivered directly to the area of concern, maximizing its effectiveness.
When using Itraconazole 0.2%/Mupirocin 0.2%/Triamcinolone 0.03% Nasal Spray, it is important to adhere to the instructions provided by your healthcare provider. Typically, the spray should be administered into each nostril twice daily, or as directed by your doctor. Ensure to shake the bottle well before each use to evenly distribute the medication.
As with any medication, side effects may occur. These may include burning, stinging, or irritation in the nasal passages. If you experience any of these or other side effects, it is important to contact your healthcare provider promptly.
If you have any questions or concerns about Itraconazole 0.2%/Mupirocin 0.2%/Triamcinolone 0.03% Nasal Spray, please do not hesitate to reach out to your healthcare provider or pharmacist. They are equipped with the knowledge and expertise to provide you with the information you need to ensure the safe and appropriate use of this medication.
This nasal spray is designed to deliver a combination of medications directly to the nasal cavity for targeted local or systemic effects. It is typically used to treat a variety of nasal conditions, depending on the specific needs of the patient.
The spray works by delivering a combination of medications directly to the nasal cavity. Itraconazole is an antifungal medication, Mupirocin is an antibiotic that prevents bacteria from growing on your skin, and Triamcinolone is a corticosteroid that reduces inflammation.
You should use this nasal spray as directed by your healthcare provider. Typically, it is sprayed into each nostril, usually once or twice a day.
If you miss a dose, use it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Use your next dose at the regular time. Do not double the dose to catch up.
Common side effects may include nasal irritation, sneezing, and nosebleeds. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
Before using this medication, tell your doctor or pharmacist if you are pregnant or breastfeeding. The effects of this medication on an unborn baby or nursing infant are unknown.
Before starting this medication, tell your doctor or pharmacist about all the products you use, including prescription drugs, nonprescription drugs, and herbal products. They can check for any potential drug interactions.
Store this medication at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away.
If you experience a severe allergic reaction, including rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing, seek medical attention immediately.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Inhale intranasally